insights_auto
Why is EDIT up 6,61%?
Dive Deeperchevron_right
EDIT:NASDAQ
Editas Medicine Inc
2,58 US$
arrow_upward
+6,61%(+0,16) 1D
2,55 US$
arrow_downward
-1,16% (-0,030)bedtimeAfter hours
Closed: 20 ოქტ, 16:00:01 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EDIT...
Open
2,40 US$
High
2,66 US$
Low
2,35 US$
Mkt. cap
396,24 მლნ.
Avg. vol.
3,03 მლნ.
Volume
0,00
52-wk high
4,21 US$
52-wk low
1,66 US$
EPS
-0,74 US$
Beta
2,00
Shares outstanding
153,58 მლნ.
No. of employees
87
Open
2,40 US$
High
2,66 US$
Low
2,35 US$
Mkt. cap
396,24 მლნ.
Avg. vol.
3,03 მლნ.
Volume
0,00
52-wk high
4,21 US$
52-wk low
1,66 US$
EPS
-0,74 US$
Beta
2,00
Shares outstanding
153,58 მლნ.
No. of employees
87
News stories
From web sources and news partners
ad-hoc-news.de
·
9 საათის წინ
Wells Fargo raises target for Editas Medicine stock from USD 4.00 to USD 6.00
Profile
Editas Medicine, Inc., is a clinical-stage biotechnology company which is developing therapies for rare diseases based on CRISPR gene editing technology. Editas headquarters is located in Cambridge, Massachusetts and has facilities in Boulder, Colorado. Wikipedia
About Editas Medicine Inc